Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Author

  • Charles Vogel
2019
2 Scopus citations
3 Scopus citations
2018

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)

Abraham, J., Caldera, H., Coleman, R., Elias, A., Goetz, M. P., Kittaneh, M., Lower, E., Mahtani, R., Terry Mamounas, E., Pegram, M., Rugo, H., Schwartzberg, L., Traina, T. & Vogel, C., May 1 2018, In : Breast cancer research and treatment. 169, 1

Research output: Contribution to journalReview article

3 Scopus citations
13 Scopus citations
2016

A non-randomized dose-escalation phase i trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors

Limentani, S. A., Csampone, M., Dorval, T., Curigliano, G., de Boer, R., Vogel, C., White, S., Bachelot, T., Canon, J. L., Disis, M., Awada, A., Berlière, M., Amant, F., Levine, E., Burny, W., Callegaro, A., De Sousa Alves, P. M., Louahed, J., Brichard, V. & Lehmann, F. F., 2016, In : Breast cancer research and treatment. 156, 2, p. 319-330 12 p.

Research output: Contribution to journalArticle

18 Scopus citations

Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer

Michiels, S., Pugliano, L., Marguet, S., Grun, D., Barinoff, J., Cameron, D., Cobleigh, M., Di Leo, A., Johnston, S., Gasparini, G., Kaufman, B., Marty, M., Nekljudova, V., Paluch-Shimon, S., Penault-Llorca, F., Slamon, D., Vogel, C., von Minckwitz, G., Buyse, M. & Piccart, M., Jun 18 2016, In : Annals of Oncology. 27, 6, p. 1029-1034 6 p.

Research output: Contribution to journalArticle

19 Scopus citations

When can a salvage therapy (T-DM1) take the lead?

Mahtani, R. & Vogel, C., Oct 10 2016, In : Journal of Clinical Oncology. 34, 29, p. 3492-3494 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations
2015

Defining the survival benchmark for breast cancer patients with systemic relapse

Zeichner, S. B., Ambros, T., Zaravinos, J., Montero, A. J., Mahtani, R. L., Ahn, E. R., Mani, A., Markward, N. J. & Vogel, C. L., Feb 12 2015, In : Breast Cancer: Basic and Clinical Research. 9, p. 9-17 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature

Zeichner, S. B., Herna, S., Mani, A., Ambros, T., Montero, A. J., Mahtani, R., Ahn, E. R. & Vogel, C., Sep 10 2015, In : Breast Cancer Research and Treatment. 153, 3, p. 617-624 8 p.

Research output: Contribution to journalArticle

21 Scopus citations
2014

A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer

Ambros, T., Zeichner, S. B., Zaravinos, J., Montero, A. J., Ahn, E. R., Aruna, M., Kronish, L., Mahtani, R. L. & Vogel, C. L., Jul 2014, In : Breast cancer research and treatment. 146, 1, p. 7-14 8 p.

Research output: Contribution to journalReview article

9 Scopus citations

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

Kaufman, P. A., Bloom, K. J., Burris, H., Gralow, J. R., Mayer, M., Pegram, M., Rugo, H. S., Swain, S. M., Yardley, D. A., Chau, M., Lalla, D., Yoo, B., Brammer, M. G. & Vogel, C. L., Sep 1 2014, In : Cancer. 120, 17, p. 2657-2664 8 p.

Research output: Contribution to journalArticle

29 Scopus citations

Toremifene for breast cancer: A review of 20 years of data

Vogel, C. L., Johnston, M. A., Capers, C. & Braccia, D., Feb 2014, In : Clinical breast cancer. 14, 1, p. 1-9 9 p.

Research output: Contribution to journalReview article

31 Scopus citations
2013

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

Mackey, J. R., Martin, M., Pienkowski, T., Rolski, J., Guastalla, J. P., Sami, A., Glaspy, J., Juhos, E., Wardley, A., Fornander, T., Hainsworth, J., Coleman, R., Modiano, M. R., Vinholes, J., Pinter, T., Rodríguez-Lescure, Á., Colwell, B., Whitlock, P., Provencher, L., Laing, K. & 10 others, Walde, D., Price, C., Hugh, J. C., Childs, B. H., Bassi, K., Lindsay, M. A., Wilson, V., Rupin, M., Houé, V. & Vogel, C., Jan 1 2013, In : The Lancet Oncology. 14, 1, p. 72-80 9 p.

Research output: Contribution to journalArticle

129 Scopus citations

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: A randomized Phase II study comparing the incidence of peripheral neuropathy

Vahdat, L. T., Garcia, A. A., Vogel, C., Pellegrino, C., Lindquist, D. L., Iannotti, N., Gopalakrishna, P. & Sparano, J. A., Jul 1 2013, In : Breast cancer research and treatment. 140, 2, p. 341-351 11 p.

Research output: Contribution to journalArticle

39 Scopus citations

Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: A pooled analysis

Pajares, B., Pollán, M., Martín, M., Mackey, J. R., Lluch, A., Gavila, J., Vogel, C., Ruiz-Borrego, M., Calvo, L., Pienkowski, T., Rodríguez-Lescure, Á., Seguí, M. A., Tredan, O., Antón, A., Ramos, M., Cámara, M. D. C., Rodríguez-Martín, C., Carrasco, E. & Alba, E., Nov 6 2013, In : Breast Cancer Research. 15, 6, R105.

Research output: Contribution to journalArticle

32 Scopus citations